Orcesi S, La Piana R, Fazzi E. Aicardi-Goutieres syndrome. Br Med Bull 2009; 89: 183-201
Brancati F, Iannicelli M, Travaglini L, Mazzotta A, Bertini E, Boltshauser E, D’Arrigo S, Emma F, Fazzi E, Gallizzi R, Gentile M, Loncarevic D, Mejaski-Bosnjak V, Pantaleoni C, Rigoli L, Salpietro CD, Signorini S, Stringini GR, Verloes A, Zabloka D, Dallapiccola B, Gleeson JG, Valente EM. MKS3/TMEM67 mutations are a major cause of COACH Syndrome, a Joubert syndrome related disorder with liver involvement. Hum Mutat 2009; 30(2):E432-42
Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Klepper J, Jehle RS, Kim HD, Liu YM, Nation J, Nordli Jr DR, Pfeifer HH, Rho JM, Stafstrom CE, Thiele EA, Turner Z, Wirrell EC, Wheless JW, Veggiotti P, Vining EP. Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009; 50(2):304-17
Mercuri E, Messina S, Bruno C, Mora M, Pegoraro E, Comi GP, D’Amico A, Aiello C, Biancheri R, Berardinelli A, Boffi P, Cassandrini D, Laverda A, Moggio M, Morandi L, Moroni I, Pane M, Pezzani R, Pichiecchio A, Pini A, Minetti C, Mongini T, Mottarelli E, Ricci E, Ruggieri A, Saredi S, Scuderi C, Tessa A, Toscano A, Tortorella G, Trevisan CP, Uggetti C, Vasco G, Santorelli FM, Bertini E. Congenital muscular dystrophies with defective glycosylation of dystroglycan. A population study. Neurology 2009; 72(21):1802-9
Facchin P, Rosa-Rizzotto M, Turconi AC, Pagliano E, Fazzi E, Stortini M, Fedrizzi E, The Gipci Studi Group: Multisite trial on efficacy of constraint-induced movement. Multisite Trial on Efficacy of Constraint-Induced Movement Therapy in Children with Hemiplegia Study Design and Methodology therapy in children with hemiplegia: study design and methodology.Am J Phys Med Rehabil 2009; 88: 216-30
Spinillo A, Montanari L, Gardella B, Roccio M, Stronati M, Fazzi E. Infant sex, obstetric risk factors, and 2-year neurodevelopmental outcome among preterm infants. Dev Med Child Neurol 2009; 51: 518-525
Capovilla G, Striano P, Gambardella A, Beccaria F, Hirsch E, Casellato S, Romeo A, Rubboli G, Sofia V, Teutonico F, Valenti MP, Striano S. Eyelid fluttering, typical EEG pattern, and impaired intellectual function: A homogeneous epileptic condition among the patients presenting with eyelid myoclonia (p ). Epilepsia 2009; 50(6):1536-1541
Ravaglia S, Moglia A, Costa A, Repetto A, Danesino C. Enzyme replacement therapy in late-onset type II glycogenosis (p ). Eur J Neurol 2009; 16(7): e125
Ravaglia S, Moglia A, Bogdanov EI. Presyrinx in children with Chiari malformations.Neurology 2009; 72(22):1966-7
Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, Ali M, Gornall H, Couthard LR, Aeby A, Attard-Montalto SP, Bertini E, Bodemer C, Brockmann K, Brueton LA, Corry PC, Desguerre I, Fazzi E, Cazorla AG, Gener B, Hamel BC, Heiberg A, Hunter M, van der Knaap MS, Kumar R, Lagae L, Landrieu PG, Lourenco CM, Marom D, McDermott MF, van der Merwe W, Orcesi S, Prendiville JS, Rasmussen M, Shalev SA, Soler DM, Shinawi M, Spiegel R, Tan TY, Vanderver A, Wakeling EL, Wassmer E, Whittaker E, Lebon P, Stetson DB, Bonthron DT, Crow YJ. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 2009;41(7):829-32
Pichiecchio A, Poloni GU, Ravaglia S, Ponzio M, Germani G, Maranzana D, Costa A,Repetto A, Tavazzi E, Danesino C, Moglia A, Bastianello S. Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? Muscle Nerve 2009; 40(1): 122-5
Mazzone ES, Messina S, Vasco G, Main M, Eagle M, D’Amico A, Doglio L, Politano L, Cavallaro F, Frosini S, Bello L, Magri F, Corlatti A, Zucchini E, Brancalion B, Rossi F, Ferretti M, Motta MG, Cecio MR, Berardinelli A, Alfieri P, Mongini T, Pini A, Astrea G, Battini R, Comi G, Pegoraro E, Morandi L, Pane M, Angelini C, Bruno C, Villanova M, Vita G, Donati MA, Bertini E, Mercuri E. Reliability of the North Star Ambulatory Assessment in a multicentric setting.Neuromuscul Disord 2009; 19 (7):458-61
Bielas SL, Silhavy JL, Brancati F, Kisseleva MV, Al-Gazali L, Sztriha L, Bayoumi RA, Zaki MS, Abdel-Aleem A, Rosti RO, Kayserili H, Swistun D, Scott LC, Bertini E, Boltshauser E, Fazzi E, Travaglini L, Field SJ, Gayral S, Jacoby M, Schurmans S, Dallapiccola B, Majerus PW, Valente EM, Gleeson JG. Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat Genet 2009; 41(9):1032-6
Izzotti A, Pulliero A, Orcesi Simona, Cartiglia C, Longobardi MG, Capra V, Lebon P, Cama A, La Piana R, Lanzi G, Fazzi E. Interferon-related transcriptome alterations in the cerebro spinal fluid cells of Aicardi-Goutières patients. Brain Pathology 2009; 19(4):650-60
Balottin U, Rossi M, Rossi G, Viganò L, Nanti M, Salini S, Lanzi G, Termine C. The Rorschach test and Gilles de la Tourette’s syndrome: A pilot case-control study. Brain Dev 2009; 31(9):657-65
Travaglini L, Brancati F, Attie-Bitach T, Audollent S, Bertini E, Kaplan J, Perrault I, […],Fazzi E, […] Signorini S, Uggetti C, […]. Expanding CEP290 mutational spectrum in ciliopathies. Am J Med Genet A 2009; 149A(10): 2173-80
Tonin P, Bruno C, Cassandrini D, Savio C, Tavazzi E, Tomelleri G, Piccolo G. Unusual presentation of phosphoglycerate mutase deficiency due to two different mutations in PGAM-M gene. Neuromuscul Disord. 2009; 19(11):776-8
Coccini T, Crevani A, Rossi G, Assandri F, Balottin U, Nardo RD, Manzo L. Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder. Biomarkers 2009; 14(7):513-22
Fazzi E, Bova S, Giovenzana A, Signorini S, Uggetti C, Bianchi P. Cognitive visual dysfunctions in preterm children with periventricular leukomalacia. Dev Med Child Neurol 2009; 51(12):974-81
Uggetti C, La Piana R, Orcesi S, Egitto MG, Crow YJ, Fazzi E. Aicardi-Goutieres Syndrome: Neuroradiologic Findings and Follow-Up. AJNR Am J Neuroradiol 2009; 30(10):1971-6
De Filippi P, Zecca M, Lisini D, Rosti V, Cagioni C, Carlo-Stella C, Radi O, Veggiotti P, Mastronuzzi A, Acquaviva A, D’Ambrosio A, Locatelli F, Danesino C. Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.Br J Haematol 2009; 147(5):706-9
Raucci U, Longhi R, Calmieri A, Osti M, Scateni S, Tozzi AE, Reale A, Rimini A, Giada F, Foglia Manzillo G, Francese GM, Ammirati F, Drago F, Semproni G, Campisi M, Rando F, Giordano U, Veggiotti P, Vigevano F, Di Capua M. La sincope in età pediatrica. Linee Guida a cura di SIP, SIMEUP, SICP, FMSI, AIAC SIC SPORT, FIMP, GSCP, GSMESPO, SINPIA, SINC.Minerva Pediatr ,2008 Oct;60(5):840-845
Balestri P, Longhi R, Franzoni E, Grosso S, Iannetti P, Pavone L, Verrotti A, Messi G, Palmieri A, Capovilla G, Mastrangelo M, Romeo A, Vigevano F, Coppola G, Dalla Bernardina B, Gobbi G, Parmeggiani A, Veggiotti P, Ballestrazzi A, Del Gobbo L, Bascelli E, Masiero G, Albani F, Bernardi B, Galluzzi P, De Martino M. La gestione del bambino con convulsioni febbrili: linee guida sulle convulsioni febbrili. Minerva Pediatr, 2008 Oct;60(5):836-839